COMMUNIQUÉS West-GlobeNewswire

First Patient Imaged in Prostate Imaging Study

13/08/2018 - 00:00

MELBOURNE, Australia, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“ Telix ”, the “ Company ”), an Australian biopharmaceutical company focused on the development of diagnostic and [...]

Loxo Oncology Announces Accepted Abstracts at the IASLC 19th World Conference on Lung Cancer

10/08/2018 - 22:30

STAMFORD, Conn., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, today announced that [...]

OrthoPediatrics Corp. to Present at FDA Conference on Pediatric Devices

10/08/2018 - 22:05

WARSAW, Ind., Aug. 10, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to participate in the Pediatric Medical [...]

FDA Approves Galafold™ (migalastat) for the Treatment of Certain Adult Patients with Fabry Disease

10/08/2018 - 22:05

First Precision and First Oral Medicine for Fabry Disease Approved for 348 Amenable GLA Variants Galafold is the First New Treatment Option for Fabry Disease in the U.S. in 15+ Years Amicus Therapeutics to Host [...]

Sientra Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

10/08/2018 - 22:01

SANTA BARBARA, Calif., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq:SIEN) (the “Company”) today announced that on August 8, 2018, Paul Little received an equity award grant from the Compensation Committee of [...]

Novo Nordisk A/S - Share repurchase programme

10/08/2018 - 21:00

Bagsværd, Denmark, 10 August 2018 - As part of the up to DKK 14 billion 2018 share repurchase programme, Novo Nordisk A/S has now initiated a new share repurchase programme for an amount of up to DKK 2.4 billion in [...]

Novo Nordisk A/S purchases B shares worth DKK 954 million from Novo Holdings A/S under the 2018 share repurchase programme

10/08/2018 - 20:49

Bagsværd, Denmark, 10 August 2018 - Novo Nordisk A/S has today entered into an agreement to purchase 3,120,644 B shares (nominal DKK 0.20) of a value of DKK 954 million from Novo Holdings A/S. This transaction is part [...]

Abeona Therapeutics annonce ses résultats financiers du deuxième trimestre 2018 et les faits saillants de la société

10/08/2018 - 20:22

Conférence téléphonique des investisseurs le vendredi 10 août à 10h00 (heure de l’Est) NEW YORK et CLEVELAND, 10 août 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), une société biopharmaceutique de [...]

Milestone Scientific Schedules Second Quarter 2018 Conference Call

10/08/2018 - 19:11

LIVINGSTON, N.J., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced [...]

Orphazyme announces enrollment of first patient in Phase III clinical trial of arimoclomol for ALS

10/08/2018 - 18:19

Orphazyme A/S Company announcement No. 10/2018 Company Registration No. 32266355 Primary objective is to determine efficacy of chronic treatment with arimoclomol compared to placebo over 76 weeks Results expected in H1 [...]

Evan Leonard, MS, MMS, PA-C is Selected to the American Health Council’s Board of Physicians

10/08/2018 - 16:14

NEW YORK, Aug. 10, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Evan Leonard, MS, MMS, PA-C to its Board of Physicians for his outstanding contributions to the medical field. An assistant professor and [...]

Canada House Wellness Group Continues Strategic Transformation with the Announcement of Changes to its Board of Directors

10/08/2018 - 15:09

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased [...]

Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2019

10/08/2018 - 15:00

DUBLIN - August 10, 2018 - Medtronic plc (NYSE:MDT) announced today that it will report financial results for the first quarter of fiscal year 2019 on Tuesday, August 21, 2018. A news release will be issued at [...]

Spine Injury Solutions Schedules Second Quarter Fiscal Year 2018 Conference Call for August 15, 2018 at 10:30 a.m. EDT

10/08/2018 - 15:00

HOUSTON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), will hold an investor conference call on Wednesday, August 15, at 10:30 am (EDT) to discuss its financial results for Q2 Fiscal Year [...]

Adamis Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Update

10/08/2018 - 15:00

SAN DIEGO, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the second quarter ended June 30, 2018 and a business update. Dr. Dennis J. Carlo, [...]

Merus Announces Financial Results for the Second Quarter 2018 & Mid-year Operating Results

10/08/2018 - 14:35

MCLA-128 Phase 1/2 clinical data from the gastric cancer cohort will be presented at the European Society for Medical Oncology Congress in October 2018 UTRECHT, The Netherlands, Aug. 10, 2018 (GLOBE NEWSWIRE) -- Merus N [...]

ASLAN Pharmaceuticals Completes Recruitment for Global Phase 2 Study for Varlitinib in First Line Gastric Cancer

10/08/2018 - 14:19

SINGAPORE, Aug. 10, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (NASDAQ:ASLN) (TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in [...]

Matinas BioPharma Reports Second Quarter 2018 Financial Results and Provides Corporate Update

10/08/2018 - 14:15

– Management intently focused on advancing proprietary and highly differentiated lipid nano-crystal platform delivery technology – – Multiple discussions with strategic partners remain ongoing – – Lead platform- [...]

XBiotech Highlights Quarterly Developments

10/08/2018 - 14:00

Company Provides Updated Overview on its Clinical, Discovery and Financial Position AUSTIN, Texas, Aug. 10, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) provided an update on recent corporate and other [...]